Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)

This study has been completed.
Sponsor:
Information provided by:
University of Utah
ClinicalTrials.gov Identifier:
NCT00235703
First received: October 6, 2005
Last updated: May 4, 2006
Last verified: October 2005
  Purpose

This is a four-year study, funded by the Center for Disease Control and Prevention, related to antimicrobial resistance in rural communities. The project consists of four components: A) surveillance of antimicrobial resistance, B) promotion of appropriate antimicrobial drug prescribing, C) preliminary assessment of the environmental impact of antimicrobials, and D) the development of new antimicrobial products. Six rural communities in Utah, and six rural communities in Idaho are participating in this study. Component D is being performed by investigators at Harvard University, under the direction of Co-Investigator Roger Inouye.


Condition Intervention
Upper Respiratory Infections
Device: Antimicrobial Prescribing Decision Support

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)

Further study details as provided by University of Utah:

Estimated Enrollment: 13000
Study Start Date: October 2001
Estimated Study Completion Date: September 2005
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Suspected upper respiratory infection patients in 12 rural communities in Utah and Idaho

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00235703

Sponsors and Collaborators
University of Utah
Investigators
Principal Investigator: Matthew H. Samore, MD University of Utah
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00235703     History of Changes
Other Study ID Numbers: RS1/CCR820631-01
Study First Received: October 6, 2005
Last Updated: May 4, 2006
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Respiratory Tract Infections
Infection
Respiratory Tract Diseases
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on July 20, 2014